Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4918
Source ID: NCT01111955
Associated Drug: Bms-823778
Title: Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: BMS-823778|DRUG: BMS-823778|DRUG: BMS-823778|DRUG: Placebo|DRUG: Metformin
Outcome Measures: Primary: Lowering of fasting plasma glucose (FPG) throughout the study to see if there is a decrease from baseline, Within 28 days following dosing | Secondary: Pharmacokinetics (measuring trough concentrations), On days 7, 14 and 28|Pharmacodynamics (measuring daily glucose, glucose AUC, HbA1c, lipid profiles, HPA markers, free testosterone, and SHBG), Within 28 days following dosing
Sponsor/Collaborators: Sponsor: Bristol-Myers Squibb
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 62
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2010-07
Completion Date: 2011-01
Results First Posted:
Last Update Posted: 2015-10-12
Locations: Farid Marquez, Md, Hialeah, Florida, 33012, United States|Capital Clinical Reserch Center, Olympia, Washington, 98502, United States|Aurora Advanced Healthcare, Milwaukee, Wisconsin, 53209, United States|Local Institution, Blacktown, New South Wales, 2148, Australia|Local Institution, Box Hill, Victoria, 3128, Australia|Local Institution, Freemantle, Western Australia, 6959, Australia|Local Institution, Surrey, British Columbia, V4A 2H9, Canada|Local Institution, Winnipeg, Manitoba, R3E 3P4, Canada|Local Institution, Bathurst, New Brunswick, E2A 4X7, Canada|Local Institution, St. John'S, Newfoundland and Labrador, A1A 3R5, Canada|Local Institution, Thornhill, Ontario, L4J 8L7, Canada|Local Institution, Mirabel, Quebec, J7J 2K8, Canada|Local Institution, Saskatoon, Saskatchewan, S7K 7H9, Canada|Local Institution, Quebec, G1N 4V3, Canada
URL: https://clinicaltrials.gov/show/NCT01111955

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D089 Metformin small molecule DB00331 Details